nera economic consulting august 13 2004 divisions of dockets management us food and drug administration 5630 fishers lane room 1061 rockville md 20852 richard r rozek ph d senior vice president 1255 23rd street nw washington dc 20037 i 125 202 466 9295 fax 3605 rvzhard rozekqnera corn re docket no 2003p 0029 use ozone depleting substances removal essential designations dear sir or madam in the federal register notice dated june 16 for above captioned matter fda requested comments on various issues concerning proposal to remove designation albuterol mdis enclosed is a report entitled raised s proposed rule removing we prepared this assist rulemaking process national research associates inc an international firm economists was retained by glaxosmithkline analyze connection with designating non our represents independent views current projected market environments selling specializes applying microeconomics complex business legal matters
